BIIB Stock Price | Biogen Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch

Biogen’s Alzheimer’s Drug Could be Expensive

Biogen (NASDAQ: BIIB) could price its Alzheimer’s drug, Lecanemab, developed along with Essai as high as $20,000 every year, Barron’s reported on Friday, citing data from The Institute for Clinical and Economic Review. The…

Dec. 23, 2022 at 10:14 a.m. ET

on TipRanks.com